Published July 14, 2025 | Version v1
Other Open

L'enzim glutaminasa com a diana metabòlica idònia per contrarestar la resistència adquirida a la teràpia amb Palbociclib en el càncer colorectal

  • 1. ROR icon The Francis Crick Institute
  • 2. University Clinic Frankfurt
  • 3. Institute of Biomedicine of University of Barcelona (IBUB)
  • 4. ROR icon Universidad Peruana Cayetano Heredia
  • 5. Fundación General CSIC
  • 6. ROR icon Universitat de Barcelona

Description

This document contains the Catalan translation of the abstract and the graphical summary of the article “Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells” by Tarrado-Castellarnau et al. Oncogene (2025), https://doi.org/10.1038/s41388-025-03495-w. Please use this citation when referring to this work.

Files

GLSDiana+Palbociclib-Oncogene-Abstract_Catalan.pdf

Files (512.2 kB)

Additional details

Related works

Is supplement to
Journal article: 10.1038/s41388-025-03495-w (DOI)